🚀 VC round data is live in beta, check it out!
Fisher & Paykel Valuation Multiples
Discover revenue and EBITDA valuation multiples for Fisher & Paykel and similar public comparables like Smith & Nephew, Align Technology, United Imaging, Penumbra and more.
Fisher & Paykel Overview
About Fisher & Paykel
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 27% in Europe, 21% in Asia-Pacific, and the remaining 10% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
Founded
1969
HQ
Employees
7.5K
Website
Financials (LTM)
EV
$14B
Fisher & Paykel Financials
Fisher & Paykel reported last 12-month revenue of $1B and EBITDA of $452M.
In the same LTM period, Fisher & Paykel generated $860M in gross profit, $452M in EBITDA, and $271M in net income.
Revenue (LTM)
Fisher & Paykel P&L
In the most recent fiscal year, Fisher & Paykel reported revenue of $1B and EBITDA of $386M.
Fisher & Paykel expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $860M | XXX | $313M | XXX | XXX | XXX |
| Gross Margin | 64% | XXX | 26% | XXX | XXX | XXX |
| EBITDA | $452M | XXX | $386M | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | 32% | XXX | XXX | XXX |
| EBIT Margin | 27% | XXX | 25% | XXX | XXX | XXX |
| Net Profit | $271M | XXX | $225M | XXX | XXX | XXX |
| Net Margin | 20% | XXX | 19% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Fisher & Paykel Stock Performance
Fisher & Paykel has current market cap of $14B, and enterprise value of $14B.
Market Cap Evolution
Fisher & Paykel's stock price is $24.32.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14B | $14B | (0.7%) | XXX | XXX | XXX | $0.38 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFisher & Paykel Valuation Multiples
Fisher & Paykel trades at 10.6x EV/Revenue multiple, and 31.4x EV/EBITDA.
EV / Revenue (LTM)
Fisher & Paykel Financial Valuation Multiples
As of March 7, 2026, Fisher & Paykel has market cap of $14B and EV of $14B.
Equity research analysts estimate Fisher & Paykel's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Fisher & Paykel has a P/E ratio of 52.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $14B | XXX | $14B | XXX | XXX | XXX |
| EV (current) | $14B | XXX | $14B | XXX | XXX | XXX |
| EV/Revenue | 10.6x | XXX | 11.8x | XXX | XXX | XXX |
| EV/EBITDA | 31.4x | XXX | 36.7x | XXX | XXX | XXX |
| EV/EBIT | 38.9x | XXX | 46.7x | XXX | XXX | XXX |
| EV/Gross Profit | 16.5x | XXX | 45.4x | XXX | XXX | XXX |
| P/E | 52.6x | XXX | 63.5x | XXX | XXX | XXX |
| EV/FCF | 64.3x | XXX | 51.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fisher & Paykel Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Fisher & Paykel Margins & Growth Rates
Fisher & Paykel's revenue in the last 12 month grew by 11%.
Fisher & Paykel's revenue per employee in the last FY averaged $0.2M.
Fisher & Paykel's rule of 40 is 45% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Fisher & Paykel's rule of X is 61% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Fisher & Paykel Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 18% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 45% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 61% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 22% | XXX | 26% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 10% | XXX | 11% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 44% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Fisher & Paykel Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Smith & Nephew | XXX | XXX | XXX | XXX | XXX | XXX |
| Align Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| United Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| Penumbra | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonova | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fisher & Paykel M&A Activity
Fisher & Paykel acquired XXX companies to date.
Last acquisition by Fisher & Paykel was on XXXXXXXX, XXXXX. Fisher & Paykel acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Fisher & Paykel
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFisher & Paykel Investment Activity
Fisher & Paykel invested in XXX companies to date.
Fisher & Paykel made its latest investment on XXXXXXXX, XXXXX. Fisher & Paykel invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Fisher & Paykel
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fisher & Paykel
| When was Fisher & Paykel founded? | Fisher & Paykel was founded in 1969. |
| Where is Fisher & Paykel headquartered? | Fisher & Paykel is headquartered in New Zealand. |
| How many employees does Fisher & Paykel have? | As of today, Fisher & Paykel has over 7K employees. |
| Who is the CEO of Fisher & Paykel? | Fisher & Paykel's CEO is Lewis Gradon. |
| Is Fisher & Paykel publicly listed? | Yes, Fisher & Paykel is a public company listed on New Zealand Exchange. |
| What is the stock symbol of Fisher & Paykel? | Fisher & Paykel trades under FPH ticker. |
| When did Fisher & Paykel go public? | Fisher & Paykel went public in 1979. |
| Who are competitors of Fisher & Paykel? | Fisher & Paykel main competitors are Smith & Nephew, Align Technology, United Imaging, Penumbra. |
| What is the current market cap of Fisher & Paykel? | Fisher & Paykel's current market cap is $14B. |
| What is the current revenue of Fisher & Paykel? | Fisher & Paykel's last 12 months revenue is $1B. |
| What is the current revenue growth of Fisher & Paykel? | Fisher & Paykel revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Fisher & Paykel? | Current revenue multiple of Fisher & Paykel is 10.6x. |
| Is Fisher & Paykel profitable? | Yes, Fisher & Paykel is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Fisher & Paykel? | Fisher & Paykel's last 12 months EBITDA is $452M. |
| What is Fisher & Paykel's EBITDA margin? | Fisher & Paykel's last 12 months EBITDA margin is 34%. |
| What is the current EV/EBITDA multiple of Fisher & Paykel? | Current EBITDA multiple of Fisher & Paykel is 31.4x. |
| What is the current FCF of Fisher & Paykel? | Fisher & Paykel's last 12 months FCF is $221M. |
| What is Fisher & Paykel's FCF margin? | Fisher & Paykel's last 12 months FCF margin is 17%. |
| What is the current EV/FCF multiple of Fisher & Paykel? | Current FCF multiple of Fisher & Paykel is 64.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.